After that time, it should not be used, even if it still looks normal
In November 2025, the Trump Administration announced an upcoming demonstration project that will extend coverage for GLP-1s to people living with obesity and related complications starting later in 2026
Factors to Consider Scope of Care: First, Joi Wellness offers many health services
But it does mean the risk profile is fundamentally different from FDA-approved products, and patients need to take active responsibility for verifying the quality of what they are injecting
Once a case has gone to trial, that is when we will have a better idea of where this litigation is going
Since they are not dose-equivalent, semaglutide is started at a low dose and its dosage is increased gradually